-
Something wrong with this record ?
Bioprostheses and Mechanical Prostheses for Aortic Valve Replacement in Patients Aged 50 to 65 Years Offer Similar Long-Term Survival Rates
T. Toporcer, Š. Lukačín, A. Kraus, M. Homola, A. Bereš, M. Trebišovský, D. Radótzy, V. Rohn, A. Kolesár
Status not-indexed Language English Country Switzerland
Document type Journal Article
NLK
Directory of Open Access Journals
from 2014
PubMed Central
from 2015
Europe PubMed Central
from 2015
ProQuest Central
from 2021-01-01
Open Access Digital Library
from 2014-01-01
Health & Medicine (ProQuest)
from 2021-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2014
PubMed
39997478
DOI
10.3390/jcdd12020044
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
BACKGROUND: Aortic valve replacement (AVR) is the definitive therapy for patients with severe aortic valve stenosis (AoS). The aim of this work is to compare the effect of a mechanical prosthesis (MP) and a bioprosthesis (BP) on the survival of patients aged 50-65 years after AVR. METHODS: The retrospective analysis included 276 patients aged 50 to 65 years who had undergone isolated AVR for AoS; 161 patients were implanted with an MP and 115 with a BP. Patient survival, adjusted for age, gender and risk parameters affecting survival, was assessed. A subgroup analysis was performed on the 208 patients with a modern valve (prosthesis models that are no longer used in clinical practice were removed from the sample). RESULTS: After adjusting for risk factors for overall survival as well as for age and sex, the implantation of an MP did not have a significant effect on overall survival in comparison to a BP, at a median follow-up of 10.3 years (p = 0.477). The size of the MP had no significant effect on overall survival either (HR: 1.29; 95%CI: 0.16-10.21; p = 0.812). However, the indexed effective orifice area of the BP had a positive effect on overall survival (HR: 0.09; 95%CI: 0.01-0.78; p = 0.029). CONCLUSIONS: The estimated survival of patients aged between 50 and 65 years after implantation of a BP with a sufficiently large indexed effective orifice area may exceed that of patients with an MP.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25008562
- 003
- CZ-PrNML
- 005
- 20250422095713.0
- 007
- ta
- 008
- 250408s2025 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/jcdd12020044 $2 doi
- 035 __
- $a (PubMed)39997478
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Toporcer, Tomáš $u Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty of Pavol Jozef Šafárik University, 04001 Košice, Slovakia $1 https://orcid.org/0000000341955180 $7 xx0106536
- 245 10
- $a Bioprostheses and Mechanical Prostheses for Aortic Valve Replacement in Patients Aged 50 to 65 Years Offer Similar Long-Term Survival Rates / $c T. Toporcer, Š. Lukačín, A. Kraus, M. Homola, A. Bereš, M. Trebišovský, D. Radótzy, V. Rohn, A. Kolesár
- 520 9_
- $a BACKGROUND: Aortic valve replacement (AVR) is the definitive therapy for patients with severe aortic valve stenosis (AoS). The aim of this work is to compare the effect of a mechanical prosthesis (MP) and a bioprosthesis (BP) on the survival of patients aged 50-65 years after AVR. METHODS: The retrospective analysis included 276 patients aged 50 to 65 years who had undergone isolated AVR for AoS; 161 patients were implanted with an MP and 115 with a BP. Patient survival, adjusted for age, gender and risk parameters affecting survival, was assessed. A subgroup analysis was performed on the 208 patients with a modern valve (prosthesis models that are no longer used in clinical practice were removed from the sample). RESULTS: After adjusting for risk factors for overall survival as well as for age and sex, the implantation of an MP did not have a significant effect on overall survival in comparison to a BP, at a median follow-up of 10.3 years (p = 0.477). The size of the MP had no significant effect on overall survival either (HR: 1.29; 95%CI: 0.16-10.21; p = 0.812). However, the indexed effective orifice area of the BP had a positive effect on overall survival (HR: 0.09; 95%CI: 0.01-0.78; p = 0.029). CONCLUSIONS: The estimated survival of patients aged between 50 and 65 years after implantation of a BP with a sufficiently large indexed effective orifice area may exceed that of patients with an MP.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Lukačín, Štefan $u Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty of Pavol Jozef Šafárik University, 04001 Košice, Slovakia $1 https://orcid.org/0000000159225958
- 700 1_
- $a Kraus, Andrea $u Institute of Mathematics and Statistics, Faculty of Science, Masaryk University, 602 00 Brno, Czech Republic
- 700 1_
- $a Homola, Marián $u Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty of Pavol Jozef Šafárik University, 04001 Košice, Slovakia $1 https://orcid.org/0009000880215453
- 700 1_
- $a Bereš, Anton $u Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty of Pavol Jozef Šafárik University, 04001 Košice, Slovakia
- 700 1_
- $a Trebišovský, Michal $u Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty of Pavol Jozef Šafárik University, 04001 Košice, Slovakia $1 https://orcid.org/0009000296075949
- 700 1_
- $a Radótzy, Denis $u Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty of Pavol Jozef Šafárik University, 04001 Košice, Slovakia
- 700 1_
- $a Rohn, Vilém $u II. Surgery Department-Cardiovascular Surgery, General University Hospital and First Faculty of Medicine, Charles University, 128 08 Prague, Czech Republic
- 700 1_
- $a Kolesár, Adrián $u Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty of Pavol Jozef Šafárik University, 04001 Košice, Slovakia $1 https://orcid.org/0000000293907191
- 773 0_
- $w MED00194905 $t Journal of cardiovascular development and disease $x 2308-3425 $g Roč. 12, č. 2 (2025)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39997478 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250408 $b ABA008
- 991 __
- $a 20250422095714 $b ABA008
- 999 __
- $a ok $b bmc $g 2306420 $s 1245637
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2025 $b 12 $c 2 $e 20250126 $i 2308-3425 $m Journal of cardiovascular development and disease $n J Cardiovasc Dev Dis $x MED00194905
- LZP __
- $a Pubmed-20250408